Motility drugs are prescription medications that speed up the muscle contractions moving food through your stomach and intestines.
A stomach that empties far too slowly turns every meal into a gamble: early fullness, bloating, and nausea hours after eating. The drugs that treat it are the main tool doctors have, and the U.S. formulary is narrower than most people expect.
This complete guide to GI motility medications covers what these drugs do, which ones U.S. doctors can prescribe, and the side effects worth knowing before you start one.
What Motility Drugs Do — And What They Don’t
Motility drugs, also called prokinetics, boost the muscle contractions that push food and waste through the digestive tract, which speeds up stomach emptying. They are not nausea drugs: they change how fast the gut moves, not how queasy you feel.
Gastroparesis, a condition where the stomach empties far too slowly, is where prokinetics are considered first-line treatment. The same medications appear in some reflux cases and in intestinal pseudo-obstruction.
Four families do this work:
- Dopamine antagonists: metoclopramide and domperidone.
- Motilin agonists, mostly macrolide antibiotics: erythromycin, azithromycin, clarithromycin.
- Serotonin 5-HT4 agonists: prucalopride and tegaserod. Cisapride, an older 5-HT4 drug, was withdrawn over cardiac side effects.
- Cholinergic agents: bethanechol, neostigmine, pyridostigmine, and baclofen.
Antiemetics are a separate category. Ondansetron, promethazine, prochlorperazine, and aprepitant ease nausea and vomiting without speeding stomach emptying, and mixing the two groups up is one of the most common mistakes people make.
Prokinetics are prescribed for confirmed motility problems, not for ordinary indigestion. If food is already moving through at a normal rate, speeding it up does not help and adds risk.
Which Motility Drugs Are Approved In The U.S.?
Every other option is off-label, restricted to a special access program, or off the market entirely.
| Medication | Drug Class | U.S. Status |
|---|---|---|
| Metoclopramide (pill) | Dopamine antagonist | — |
| Metoclopramide (nasal spray) | Dopamine antagonist | Approved for diabetic gastroparesis |
| Metoclopramide (injection) | Dopamine antagonist | Approved; used in clinical settings |
| Erythromycin | Motilin agonist (macrolide) | Used off-label; effect fades |
| Azithromycin | Motilin agonist (macrolide) | Used off-label |
| Domperidone | Dopamine antagonist | Not approved; expanded access only |
| Prucalopride | 5-HT4 agonist | Approved for chronic constipation; not for gastroparesis |
| Cisapride | 5-HT4 agonist | Withdrawn over cardiac side effects |
| Bethanechol | Cholinergic agent | Older agent; limited use today |
Metoclopramide comes in three forms: a pill, a nasal spray, and a shot. The spray was recently approved for diabetic gastroparesis, and Mayo Clinic’s gastroparesis treatment guidance notes it causes fewer side effects than the pill form.
Erythromycin is the most common alternative prokinetic, but it can lose its effect over time and often causes diarrhea.
The injection form is used mainly in clinical settings, such as when someone cannot keep a pill down.
If you are comparing options and want the practical differences in one place, our comparison of motility drug options walks through what each one is used for.
Risks, Warnings, And What To Ask Your Doctor
The biggest safety flag belongs to metoclopramide, which carries a boxed warning for tardive dyskinesia, a movement disorder that can persist after the drug is stopped. That warning is one reason treatment is kept as short as possible.
Mayo Clinic notes the nasal spray causes fewer side effects than the pill, but the boxed warning applies to metoclopramide in every form.
Cisapride was pulled from the market over cardiac problems. Erythromycin’s diarrhea is the most common reason people stop taking it.
None of these drugs fixes the underlying cause of slow motility. They buy comfort and time while a doctor looks for what is driving it, whether that is diabetes, prior surgery, or nerve damage.
NHS Specialist Pharmacy Service guidance on choosing a prokinetic for impaired gastrointestinal motility treats the choice as a match between drug and problem, rather than one approach for every slow gut.
Practically, that leaves three questions for your doctor: whether metoclopramide suits you, how long you should take it, and what the next step is if it does not work. Erythromycin is usually that next step; after that, the options thin out fast.
Common Questions
Are motility drugs the same as anti-nausea medications?
No. Antiemetics such as ondansetron, promethazine, prochlorperazine, and aprepitant reduce nausea and stop vomiting, but they do not speed up stomach emptying. Prokinetics work on the muscle of the gut itself. Some people need both kinds at once, which is why doctors often prescribe them together.
Why is domperidone not available in the United States?
The only route to it is the FDA’s expanded access program for investigational drugs, which requires a doctor to file a request.
Do prokinetic drugs stop working over time?
Some do. Erythromycin is the clearest example: it commonly loses effectiveness with continued use, and diarrhea is a frequent side effect. That fading effect is one reason doctors often reserve it for short stretches or switch to another agent instead of relying on it long term.
Sources
- Mayo Clinic.
- NIH / NCBI Bookshelf. “Gastroparesis” Covers prokinetic drug classes and first-line use in gastroparesis.
- NHS Specialist Pharmacy Service. “Choosing a prokinetic medicine for impaired gastrointestinal motility” Guidance on matching a prokinetic to a specific motility problem.